Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

967474

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have to secure funding for existing prescribed medicines withdrawal centres.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9967
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9968 HL9969 HL9971 question first answered 17/09/2018 14:06:06 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

967475

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have, if any, to increase the number of prescribed medicines withdrawal centres to cover the whole of England.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9968
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9967 HL9969 HL9971 question first answered 17/09/2018 14:06:06 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

967476

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they will ensure that in establishing a 24 hour helpline for people affected by prescribed medicines addiction they will also ensure that adequate services are in place to refer patients to.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9969
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9967 HL9968 HL9971 question first answered 17/09/2018 14:06:06 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1648881

	registered interest
	date	29/06/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what data his Department collects on levels of (a) dependence on and (b) treatment for dependence on prescribed drugs.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Cat Smith
	uin	191813
	answer	answer is ministerial correction date of answer 10/07/2023 answer text <p>The Department does not collect data on levels of dependence on and treatment for dependence on prescribed drugs. The National Institute for Health and Care Excellence (NICE) has published a range of evidence-based guidance that includes recommendations for the National Health Service on the use of benzodiazepines, z drugs and anti-depressants based on an assessment of their benefits and longer-term health impacts. The guidance ‘Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults’ which is available at the following link:</p><p><a href="http://www.nice.org.uk/guidance/ng215" target="_blank">www.nice.org.uk/guidance/ng215</a></p><p>The Department has no current plans to assess the publication’s effectiveness of ‘Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms: Framework for action for integrated care boards (ICBs) and primary care’.</p> answering member constituency Harborough answering member printed Neil O'Brien grouped question UIN 191814 191815 question first answered 10/07/2023 16:15:39 answering member 4679 label Biography information for Neil O'Brien
	tabling member	4436 label Biography information for Cat Smith

1648883

	registered interest
	date	29/06/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the report by NHS England entitled Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms: framework for action for integrated care boards and primary care, published in March 2023, what plans he has to assess the effectiveness of that framework for action.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Cat Smith
	uin	191815
	answer	answer is ministerial correction date of answer 10/07/2023 answer text <p>The Department does not collect data on levels of dependence on and treatment for dependence on prescribed drugs. The National Institute for Health and Care Excellence (NICE) has published a range of evidence-based guidance that includes recommendations for the National Health Service on the use of benzodiazepines, z drugs and anti-depressants based on an assessment of their benefits and longer-term health impacts. The guidance ‘Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults’ which is available at the following link:</p><p><a href="http://www.nice.org.uk/guidance/ng215" target="_blank">www.nice.org.uk/guidance/ng215</a></p><p>The Department has no current plans to assess the publication’s effectiveness of ‘Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms: Framework for action for integrated care boards (ICBs) and primary care’.</p> answering member constituency Harborough answering member printed Neil O'Brien grouped question UIN 191813 191814 question first answered 10/07/2023 16:15:39 answering member 4679 label Biography information for Neil O'Brien
	tabling member	4436 label Biography information for Cat Smith

1648882

	registered interest
	date	29/06/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential long-term health impacts of (a) benzodiazepines, (b) z drugs and (c) antidepressants on people that take those drugs.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Cat Smith
	uin	191814
	answer	answer is ministerial correction date of answer 10/07/2023 answer text <p>The Department does not collect data on levels of dependence on and treatment for dependence on prescribed drugs. The National Institute for Health and Care Excellence (NICE) has published a range of evidence-based guidance that includes recommendations for the National Health Service on the use of benzodiazepines, z drugs and anti-depressants based on an assessment of their benefits and longer-term health impacts. The guidance ‘Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults’ which is available at the following link:</p><p><a href="http://www.nice.org.uk/guidance/ng215" target="_blank">www.nice.org.uk/guidance/ng215</a></p><p>The Department has no current plans to assess the publication’s effectiveness of ‘Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms: Framework for action for integrated care boards (ICBs) and primary care’.</p> answering member constituency Harborough answering member printed Neil O'Brien grouped question UIN 191813 191815 question first answered 10/07/2023 16:15:39 answering member 4679 label Biography information for Neil O'Brien
	tabling member	4436 label Biography information for Cat Smith

1276369

	registered interest
	date	13/01/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 October 2020 to Question 95679 on Drugs: Misuse, for what reason the independent review by Dame Carol Black into illicit drug use will inform the implementation of recommendations relating to prescription drug dependency.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Cat Smith
	uin	137237
	answer	answer is ministerial correction date of answer 27/01/2021 answer text <p>Phase two of Dame Carol Black’s review covering treatment services will be published later this year and will be made available to the National Oversight Group overseeing the National Health Service’s implementation of recommendations from Public Health England’s prescribed medicines review alongside other relevant materials.</p><p>Medicines optimisation is defined in the National Institute for Health and Care Excellence’s guidelines as ‘a person-centred approach to safe and effective medicines use, to ensure people obtain the best possible outcomes from their medicines’. This includes prescription of medicines which may give rise to dependency when these are clinically justified.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 137236 question first answered 27/01/2021 14:04:30 answering member 4380 label Biography information for Jo Churchill
	tabling member	4436 label Biography information for Cat Smith

1056912

	registered interest
	date	07/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what is the timetable for the review by Public Health England of prescribed drugs dependence and withdrawal; and what assessment they have made of the progress of the review against that timetable.
	tabling member printed	The Earl of Sandwich
	uin	HL13566
	answer	answer is ministerial correction date of answer 20/02/2019 answer text <p>Public Health England’s review of dependence on, or withdrawal from, prescribed medications is currently scheduled to be published in July 2019.</p><p>Some of the methods being used are in the process of being enhanced, in response to the interim findings, to ensure that the final findings are robust.</p> answering member printed Baroness Blackwood of North Oxford question first answered 20/02/2019 14:08:09 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	2109 label Biography information for The Earl of Sandwich

1149994

	registered interest
	date	16/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle addiction to prescription drugs.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	1039
	answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>The Government takes the issue of dependence to prescribed drugs very seriously and is taking action to protect people from inappropriate prescribing. In September 2019, Public Health England (PHE) published a review of available data and evidence on the problems of dependence and withdrawal associated with some prescribed medicines.</p><p>The review assessed the scale and distribution of the problem and made recommendations for better monitoring and treatment. The full report, summary of the review and information for patients on what the review means for them can be accessed at the following link:</p><p><a href="https://www.gov.uk/government/publications/prescribed-medicines-review-report" target="_blank">https://www.gov.uk/government/publications/prescribed-medicines-review-report</a></p><p>The Government will consider the report in future policy development in this area. Additionally, the Government has introduced prominent warnings for all opioid medicines and is making sure prevention and social prescribing are at the heart of our NHS Long Term Plan to cut down on over-prescribing.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 25/10/2019 12:55:42 answering member 4380 label Biography information for Jo Churchill
	tabling member	4131 label Biography information for Jim Shannon

1176630

	registered interest
	date	05/02/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have to develop and launch a national helpline which is open 24 hours every day to support those affected by prescribed drug dependence; and whether such a service will be developed with the input of relevant charities and patient groups.
	tabling member printed	The Earl of Sandwich
	uin	HL1382
	answer	answer is ministerial correction date of answer 13/02/2020 answer text <p>In September 2019, Public Health England published an evidence review on the problems of dependence and withdrawal associated with some prescribed medicines. The review recommended the Department considers supporting the development of a time-limited national helpline and associated website. NHS England and NHS Improvement are considering the recommendations from the review, including the recommendation for a helpline, and other evidence to develop a set of actions to reduce and treat prescription medicine dependency.</p> answering member printed Baroness Blackwood of North Oxford question first answered 13/02/2020 14:49:45 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	2109 label Biography information for The Earl of Sandwich